Efficacy and safety of PD-1 blockade with JS001 in patients with advanced neuroendocrine neoplasms: A non-randomized, openlabel, phase Ib trial

Authors
Category Primary study
JournalAnnals of Oncology
Year 2018
This article has no abstract
Epistemonikos ID: e6b8270ecb382b525de8e6ee57d7705c220db6fb
First added on: Feb 11, 2025